FDA Inspection 1101815 — Interojo Inc.

Interojo Inc. — FEI 3004146030

The FDA completed an inspection of Interojo Inc. on August 29, 2019 in Pyeongtaek City. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 29, 2019
Fiscal Year
2019
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Pyeongtaek City (Korea (the Republic of))

Citations

IDCFRDescription
1471221 CFR 820.184DHR - not or inadequately maintained
2142521 CFR 820.184(f)DHR - UDI not included
311821 CFR 820.75(a)Documentation
316021 CFR 820.184Lack of or inadequate DHR procedures
63021 CFR 803.17Lack of Written MDR Procedures